Ghrelin attenuates acute pancreatitis-induced lung injury and inhibits substance P expression

American Journal of the Medical Sciences

Volumn 339, Issue 1, 2010, Pages 49-54

  Zhou, Xiaolei ^a   Xue, Chengrui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute lung injury; Acute pancreatitis; Ghrelin; Substance P

Indexed keywords

GHRELIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; SUBSTANCE P; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG FLUID; LUNG INJURY; LUNG PARENCHYMA; MALE; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 75449091802     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181b9c3d3     Document Type: Article

References (36)

1. Klöppel G. Acute pancreatitis. Semin Diagn Pathol 2004;21:221-226
2. Bhatia M. Acute pancreatitis as a model of SIRS. Front Biosci 2009;14:2042-2050
3. Liu XM, Xu J, Wang ZF. Pathogenesis of acute lung injury in rats with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2005;4: 614-617 (Pubitemid 41723824)
4. Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy 2002;1:343-351
5. Günther A, Walmrath D, Grimminger F. Pathophysiology of acute lung injury. Semin Respir Crit Care Med 2001;22:247-258
6. Malleo G, Mazzon E, Siriwardena AK, et al. TNF-alpha as a therapeutic target in acute pancreatitis-lessons from experimental models. ScientificWorldJournal 2007;7:431-448
7. Frossard JL, Saluja A, Bhagat L, et al. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis- associated lung injury. Gastroenterology 1999;116:694-701.
8. Groneberg DA, Quarcoo D, Frossard N, et al. Neurogenic mechanisms in bronchial inflammatory disease. Allergy 2004;59:1139-1152
9. O'Connor TM, O'Connell J, O'Brien DI. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167-180
10. Lau HY, Bhatia M. The effect of CP96, 345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis. J Pathol 2006;208:364-371
11. Sun J, Bhatia M. Blockade of neurokinin-1 receptor attenuates CC and CXC chemokine production in experimental acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 2007; 292:G143-53. (Pubitemid 46090259)
12. Hegde A, Zhang H, Moochhala SM, et al. Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. J Leukoc Biol 2007;82:678-685
13. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 1999;402:656-660
14. Hayashida T, Nakahara K, Mondal MS, et al. Ghrelin in neonatal rats: distribution in stomach and its possible role. J Endocrinol 2002; 173:239-245 (Pubitemid 34552452)
15. Sun Y, Wang P, Zheng H, et al. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004;101:4679-4684
16. Dixit VD, Weeraratna AT, Yang H, et al. Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility. J Biol Chem 2006;281:16681-16690
17. Malagón MM, Luque RM, Ruiz-Guerrero E, et al. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 2003;144:5372-5380
18. Maier C, Schaller G, Buranyi B, et al. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab 2004;89:4729-4733
19. Zizzari P, Halem H, Taylor J, et al. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 2005;146:3836-3842
20. Dembinski A, Warzecha Z, Ceranowicz P, et al. Ghrelin attenuates the development of acute pancreatitis in rats. J Physiol Pharmacol 2003;54:561-573
21. Wu R, Dong W, Zhou M, et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 2007;176:805-813
22. Xia SH, Fang DC, Hu CX, et al. Effect of BN52021 on NFκ-Bp65 expression in pancreatic tissues of rats with severe acute pancreatitis. World J Gastroenterol 2007;13:882-888.
23. Leme AS, Lichtenstein A, Arantes-Costa FM, et al. Acute lung injury in experimental pancreatitis in rats: pulmonary protective effects of crotapotin and N-acetylcysteine. Shock 2002;18:428-433
24. Klinger JR, Murray JD, Casserly B, et al. Rottlerin causes pulmonary edema in vivo: a possible role for PKCdelta. J Appl Physiol 2007;103:2084-2094
25. Bhatia M, Slavin J, Cao Y, et al. Preprotachykinin-A gene deletion protects mice against acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 2003;284:G830-6.
26. Bhatia M, Brady M, Zagorski J, et al. Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut 2000;47:838-844
27. de Campos T, Deree J, Martins JO. Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. Pancreas 2008;37:42-49
28. Martín Alonso MA, Santamaría A, Saracíbar E, et al. Cytokines and other immunological parameters as markers of distant organ involvement in acute pancreatitis. Med Clin (Barc) 2007;128:401-406
29. Nieber K, Baumgarten CR, Rathsack R, et al. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90(4 Pt 1):646-652
30. Puneet P, Hegde A, Ng SW, et al. Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis. J Immunol 2006;176:3813-3820
31. Beer S, Weighardt H, Emmanuilidis K, et al. Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 2002;30:1794-1798
32. Wong SS, Sun NN, Lantz RC, et al. Substance P and neutral endopeptidase in development of acute respiratory distress syndrome following fire smoke inhalation. Am J Physiol Lung Cell Mol Physiol 2004;287:L859-66.
33. Zhang H, Hegde A, Ng SW, et al. Hydrogen sulfide up-regulates substance P in polymicrobial sepsis-associated lung injury. J Immunol 2007;179:4153-4160
34. Bhatia M, Saluja AK, Hofbauer B, et al. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis associated lung injury. Proc Natl Acad Sci USA 1998;95:4760-4765
35. Yamaguchi M, Ozawa Y, Mishima H, et al. Substance P increases production of proinflammatory cytokines and formation of osteoclasts in dental pulp fibroblasts in patients with severe orthodontic root resorption. Am J Orthod Dentofacial Orthop 2008;133:690-698
36. Tokuda M, Miyamoto R, Sakuta T, et al. Substance P activates p38 mitogen-activated protein kinase to promote IL-6 induction in human dental pulp fibroblasts. Connect Tissue Res 2005;46:153-158